Figure 1.
Plasma glucose (A), insulin (B), C-peptide (C), and FFA concentrations (D) during OGTT before (BAS) and after (EOS) 16 weeks of Inhaled insulin treatment. * p < 0.05.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.